Quick Takeaways
- ARCH Venture Fund X, L.P. filed SCHEDULE 13G for Maze Therapeutics, Inc. Common Stock par value $0.0001 per share (MAZE).
- Disclosed ownership: 9.4%.
- Date of event: 31 Mar 2025.
ARCH Venture Fund X, L.P. - 31 Mar 2025 SCHEDULE 13G Report for Maze Therapeutics, Inc. Common Stock par value $0.0001 per share (MAZE)
- Filing Manager
- ARCH Venture Fund X, L.P.
- Reporting Manager
- ARCH Venture Fund X, L.P.
- Symbol
- MAZE
- Shares outstanding
- 43,830,351 shares
- Disclosed Ownership
- 4,120,053 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 17:05:19 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARCH Venture Fund X, L.P. disclosed 9.4% ownership in Maze Therapeutics, Inc. Common Stock par value $0.0001 per share (MAZE) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 17:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARCH Venture Fund X, L.P. | 9.4% | 4,120,053 | 0 | 4,120,053 | ARCH Venture Partners X, L.P. | its General Partner | |
| ARCH Venture Fund X Overage, L.P. | 9.4% | 4,120,053 | 0 | 4,120,053 | ARCH Venture Partners X Overage, L.P. | its General Partner | |
| ARCH Venture Partners X, L.P. | 9.4% | 4,120,053 | 0 | 4,120,053 | ARCH Venture Partners X, LLC | its General Partner | |
| ARCH Venture Partners X Overage, L.P. | 9.4% | 4,120,053 | 0 | 4,120,053 | ARCH Venture Partners X, LLC | its General Partner | |
| ARCH Venture Partners X, LLC | 9.4% | 4,120,053 | 0 | 4,120,053 | /s/ Mark McDonnell | * Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director | |
| Keith Crandell | 9.4% | 4,120,053 | 0 | 4,120,053 | /s/ Mark McDonnell | * Mark McDonnell, as Attorney-in-Fact for Keith Crandell | |
| Kristina Burow | 9.4% | 4,120,053 | 0 | 4,120,053 | /s/ Mark McDonnell | * Mark McDonnell, as Attorney-in-Fact for Kristina Burow | |
| Steven Gillis | 9.4% | 4,120,053 | 0 | 4,120,053 | /s/ Mark McDonnell | * Mark McDonnell, as Attorney-in-Fact for Steven Gillis | |
| Robert Nelsen | 9.4% | 4,120,053 | 0 | 4,120,053 | /s/ Mark McDonnell | * Mark McDonnell, as Attorney-in-Fact for Robert Nelsen |